SCHEMBL7976557

SCHEMBL7976557

CC(Cc1ccccc1)Cc1ccc(OCCN(C)c2nc3ccccc3o2)cc1

nearest known ligand 0.78

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.78
PPARA Q07869 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2786495 0.88 PPARG (0.84) PPARGPPARA
SCHEMBL9389101 0.86 PPARG (0.73) PPARGPPARA
SCHEMBL13891652 0.85 PPARG (0.79) PPARGPPARA
SCHEMBL7920689 0.85 PPARG (0.77) PPARGPPARA
SCHEMBL7922711 0.85 PPARG (0.80) PPARGPPARA
SCHEMBL13777316 0.85 PPARG (0.72) PPARGPPARA
SCHEMBL9086989 0.85 PPARG (0.80) PPARGPPARA
SCHEMBL9086967 0.85 PPARG (0.80) PPARGPPARA
SCHEMBL9086937 0.85 PPARG (1.00) PPARGPPARA
SCHEMBL7922721 0.85 PPARG (0.80) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294580-B1 FOR THERAPY AND PROPHYLAXIS OF TYPE II OR NON-INSULIN DEPENDENT DIABETES MELLITUS, HYPERGLYCAEMIA, DYSLIPIDEMIA, TYPE II DIABETES, TYPE I DIABETES, HYPERTRIGLYCERIDEMIA, SYNDROME X, INSULIN RESISTANCE, HEART FAILURE GLAXO WELLCOME INC. 2001-09-25 US disclosed